PFE vs VRT: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Vertiv Holdings Co — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
VS
Vertiv Holdings Co · Industrials
$333.05
-45.0% upside to fair value
Grade D
High Quality
QuantHub Verdict
PFE has more upside to fair value
(+2.8%).
PFE trades at a lower forward P/E
(19.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
VRT |
| Current Price |
$25.22 |
$333.05 |
| Fair Value Estimate |
$25.92 |
$183.18 |
| Upside to Fair Value |
+2.8%
|
-45.0%
|
| Market Cap |
$143.7B |
$127.9B |
| Forward P/E |
19.2x
|
81.8x
|
| EV / EBITDA |
12.3x
|
55.4x
|
| Price / Sales |
2.3x
|
11.8x
|
| Price / FCF |
15.2x
|
55.4x
|
| Revenue Growth YoY |
+5.4%
|
+30.1%
|
| Gross Margin |
69.3%
|
36.2%
|
| Operating Margin |
23.4%
|
18.5%
|
| Return on Equity |
8.4%
|
42.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
6.6%
|
1.81%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
Vertiv Holdings Co operates in the industrials sector, specializing in electrical equipment and parts with a strong focus on data center critical infrastructure. The company benefits from a durable competitive position supported by a broad product portfolio that drives approximately 75% of sales from data centers. Vertiv's business quality is high, demonstrated by a 42.1% return on equity, strong…
Accumulation Zones
| Metric |
PFE |
VRT |
| Zone Low |
$19.44 |
$137.38 |
| Zone High |
$22.03 |
$155.70 |
| In Buy Zone? |
No
|
No
|